Island Pharmaceuticals (ILA) Short Interest
Island Pharmaceuticals (ASX:ILA) had 0.00% of shares reported as short positions as of 17 Aug 2026, representing 4 shares. Island Pharmaceuticals operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Island Pharmaceuticals
Island Pharmaceuticals is focused on drug repurposing and clinical development for viral diseases lacking existing therapies. Their business model centers around identifying and developing solutions for unmet medical needs in the treatment of viral infections. The company aims to create value by advancing repurposed drug candidates through clinical trials and ultimately to market.
Short position
Island Pharmaceuticals (ASX:ILA) has 0.00% of its shares on issue reported as short positions as of 17 Aug 2026, or about 4 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.19% in March 2023. ILA is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Weekly context: The 10 most shorted ASX stocks — Week 34, 2026.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4ILA intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Short interest history & FAQ
Company
AI-generated research profile of Island Pharmaceuticals
Latest ILA news
All newsAbout
website
address
More Pharmaceuticals, Biotechnology & Life Sciences Stocks
Other shorted stocks in this sector
Be the first to discuss ILA
Start a research thread or post the first pulse update